Gemtesa 75 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DR26FPE6L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,866
Award facts
- Contract value 100% obligated
- $10,866.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $10,866.14 delivery order to Amerisourcebergen Drug Corp on June 18, 2026, for Gemtesa 75 mg tablets (90-count supply) with an ultimate completion date of June 22, 2026.
Place of performance is Conshohocken, PA. The order is firm fixed-price with no set-aside applied. Amerisourcebergen Drug Corp is a pharmaceutical distributor and medical supplier subsidiary of Cencora, Inc., competing on full-and-open basis across DLA Troop Support Medical indefinite delivery contracts supporting worldwide military healthcare supply.
Quick answers
Who was awarded contract SPE2DR26FPE6L?
SPE2DR26FPE6L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 18, 2026.
How much is contract SPE2DR26FPE6L worth?
The government has obligated $10,866 on SPE2DR26FPE6L.
Is contract SPE2DR26FPE6L an order under another contract?
Yes. SPE2DR26FPE6L is a delivery order under SPE2DR25D1021, an indefinite delivery contract.
Was contract SPE2DR26FPE6L competed?
The extent of competition for SPE2DR26FPE6L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award